Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
Patrick Revy(Hôpital Necker-Enfants Malades), Anne Durandy(Hôpital Necker-Enfants Malades), Nadia Catalan(Hôpital Necker-Enfants Malades), Alessandro Plebani(University of Brescia), Tasuku Honjo(Kyoto University), Nicole Brousse, Hülya Kayserili(Istanbul University), Alain Fischer(Université Claude Bernard Lyon 1), İlhan Tezcan(Hacettepe University Hospital), Masamichi Muramatsu(Kanazawa University), Monique Forveille(Hôpital Necker-Enfants Malades), Özden Sanal(Hacettepe University Hospital), Frédéric Geissmann(King's College London), Yves Lévy, Alberto G. Ugazio(University of Brescia), Taro Muto(Kyoto University), Fügen Ersoy(Hacettepe University Hospital), Kazuo Kinoshita(Shiga Medical Center), Rémi Dufourcq-Lagelouse(Hôpital Necker-Enfants Malades), Luigi D. Notarangelo(University of Brescia), Andrew R. Gennery(Hôpital Necker-Enfants Malades)
Cited by 1,627
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k